Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Magnetic microparticle aggregation for viscosity determination by MR.

Hong R, Cima MJ, Weissleder R, Josephson L.

Magn Reson Med. 2008 Mar;59(3):515-20. doi: 10.1002/mrm.21526.

2.

T2 relaxation induced by clusters of superparamagnetic nanoparticles: Monte Carlo simulations.

Matsumoto Y, Jasanoff A.

Magn Reson Imaging. 2008 Sep;26(7):994-8. doi: 10.1016/j.mri.2008.01.039.

PMID:
18479873
3.

Liquid oral magnetic particles as a gastrointestinal contrast agent for MR imaging: efficacy in vivo.

Rubin DL, Muller HH, Sidhu MK, Young SW, Hunke WA, Gorman WG.

J Magn Reson Imaging. 1993 Jan-Feb;3(1):113-8.

PMID:
8428076
4.

Iron oxides as MR imaging contrast agents.

Fahlvik AK, Klaveness J, Stark DD.

J Magn Reson Imaging. 1993 Jan-Feb;3(1):187-94. Review. No abstract available.

PMID:
8428086
5.

Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents.

Di Marco M, Sadun C, Port M, Guilbert I, Couvreur P, Dubernet C.

Int J Nanomedicine. 2007;2(4):609-22. Review.

6.

Structure activity relationship of magnetic particles as MR contrast agents.

Thomassen T, Wiggen UN, Gundersen HG, Fahlvik AK, Aune O, Klaveness J.

Magn Reson Imaging. 1991;9(2):255-8.

PMID:
2034059
7.

Important considerations in the design of iron oxide nanoparticles as contrast agents for TI-weighted MRI and MRA.

Kellar KE, Fujii DK, Gunther WH, Briley-Saebø K, Bjornerod A, Spiller M, Koenig SH.

Acad Radiol. 2002 May;9 Suppl 1:S34-7. No abstract available.

PMID:
12019889
8.

MR relaxivity measurement of iron oxide nano-particles for MR lymphography applications.

Firouznia K, Amirmohseni S, Guiti M, Amanpour S, Baitollahi A, Kharadmand AA, Mohagheghi MA, Oghabian MA.

Pak J Biol Sci. 2008 Feb 15;11(4):607-12.

PMID:
18817134
9.

Investigation of the magnetic properties of iron oxide nanoparticles used as contrast agent for MRI.

Pouliquen D, Perroud H, Calza F, Jallet P, Le Jeune JJ.

Magn Reson Med. 1992 Mar;24(1):75-84.

PMID:
1556931
10.

RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography.

Bremer C, Allkemper T, Baermig J, Reimer P.

J Magn Reson Imaging. 1999 Sep;10(3):461-7.

PMID:
10508309
11.

Superparamagnetic agents: physicochemical characteristics and preclinical imaging evaluation.

Benderbous S, Corot C, Jacobs P, Bonnemain B.

Acad Radiol. 1996 Aug;3 Suppl 2:S292-4. No abstract available.

PMID:
8796583
12.

Three types of physical measurements needed to characterize iron oxide nanoparticles for MRI and MRA: magnetization, relaxometry, and light scattering.

Koenig SH, Kellar KE, Fujii DK, Gunther WH, Briley-Saebø K, Spiller M.

Acad Radiol. 2002 May;9 Suppl 1:S5-10. No abstract available.

PMID:
12019893
13.
14.

Liver-directed superparamagnetic iron oxide: quantitation of T2 relaxation effects.

Pouliquen D, Lucet I, Chouly C, Perdrisot R, Le Jeune JJ, Jallet P.

Magn Reson Imaging. 1993;11(2):219-28.

PMID:
8455432
15.

Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors.

Varallyay P, Nesbit G, Muldoon LL, Nixon RR, Delashaw J, Cohen JI, Petrillo A, Rink D, Neuwelt EA.

AJNR Am J Neuroradiol. 2002 Apr;23(4):510-9.

16.

Frequency dependence of MR relaxation times. II. Iron oxides.

Bulte JW, Vymazal J, Brooks RA, Pierpaoli C, Frank JA.

J Magn Reson Imaging. 1993 Jul-Aug;3(4):641-8.

PMID:
8347958
17.

Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10.

Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi C, Corot C.

Invest Radiol. 2004 Jan;39(1):56-63.

PMID:
14701989
18.

Influence of viscosity on WIN 39996 as a contrast agent for gastrointestinal magnetic resonance imaging.

Rubin DL, Muller HH, Young SW, Hunke WA, Gorman WG, Lee KC.

Invest Radiol. 1995 Apr;30(4):226-31.

PMID:
7635672
19.

Real-time imaging of convection-enhanced delivery of viruses and virus-sized particles.

Szerlip NJ, Walbridge S, Yang L, Morrison PF, Degen JW, Jarrell ST, Kouri J, Kerr PB, Kotin R, Oldfield EH, Lonser RR.

J Neurosurg. 2007 Sep;107(3):560-7.

PMID:
17886556
20.

'NC100150', a preparation of iron oxide nanoparticles ideal for positive-contrast MR angiography.

Kellar KE, Fujii DK, Gunther WH, Briley-Saebø K, Spiller M, Koenig SH.

MAGMA. 1999 Aug;8(3):207-13.

PMID:
10504049
Items per page

Supplemental Content

Support Center